Pb(Mg_(1/3)Nb_(2/3))O_(3)–PbTiO_(3)(PMN-PT)piezoelectric ceramics have excellent piezoelectric properties and are used in a wide range of applications.Adjusting the solid solution ratios of PMN/PT and different conce...Pb(Mg_(1/3)Nb_(2/3))O_(3)–PbTiO_(3)(PMN-PT)piezoelectric ceramics have excellent piezoelectric properties and are used in a wide range of applications.Adjusting the solid solution ratios of PMN/PT and different concentrations of elemental doping are the main methods to modulate their piezoelectric coefficients.The combination of these controllable conditions leads to an exponential increase of possible compositions in ceramics,which makes it not easy to extend the sample data by additional experimental or theoretical calculations.In this paper,a physics-embedded machine learning method is proposed to overcome the difficulties in obtaining piezoelectric coefficients and Curie temperatures of Sm-doped PMN-PT ceramics with different components.In contrast to all-data-driven model,physics-embedded machine learning is able to learn nonlinear variation rules based on small datasets through potential correlation between ferroelectric properties.Based on the model outputs,the positions of morphotropic phase boundary(MPB)with different Sm doping amounts are explored.We also find the components with the best piezoelectric property and comprehensive performance.Moreover,we set up a database according to the obtained results,through which we can quickly find the optimal components of Sm-doped PMN-PT ceramics according to our specific needs.展开更多
目的:分析来那度胺、硼替佐米及地塞米松(lenalidomide,bortezomib and dexamethasone,RVD)方案治疗新诊断多发性骨髓瘤(newly diagnosed multiple myeloma,NDMM)患者的疗效和安全性.方法:回顾性分析2015年1月至2019年5月首都医科大学...目的:分析来那度胺、硼替佐米及地塞米松(lenalidomide,bortezomib and dexamethasone,RVD)方案治疗新诊断多发性骨髓瘤(newly diagnosed multiple myeloma,NDMM)患者的疗效和安全性.方法:回顾性分析2015年1月至2019年5月首都医科大学附属北京朝阳医院收治的48例NDMM患者,统计其临床特征及治疗疗效.结果:48例患者的中位年龄为59(34~79)岁,Durie-Salmon分期Ⅲ期患者44例;ISS分期Ⅱ期患者15例,Ⅲ期患者19例,12例伴浆细胞瘤,细胞遗传学高危患者占32.5%.全部患者接受RVD方案化疗,中位4(1~9)个周期,总有效率97.9%,完全缓解(complete response,CR)率为35.4%,4个周期较2个周期化疗后非常好的部分缓解(very good partial response,VGPR)以上疗效提高为(84.6% vs. 64.1%);平均采集CD34+细胞数4.2(±2.6)×106/kg;诱导治疗后下一代流式微小残留病变(minimal residual disease,MRD)阴性率为20.6%,其中2例移植前MRD阳性者在移植后MRD转阴.治疗过程中2例发生3~4级血液学毒性,未发生3级以上非血液学不良事件.结论:采用RVD方案治疗NDMM患者4个疗程,缓解率高,不良反应可耐受,且不影响干细胞采集.RVD诱导联合自体造血干细胞移植可进一步提高MRD阴性率.展开更多
基金Project supported by the National Natural Science Foundation of China (Grant Nos.52272116 and 12002400)the Natural Science Foundation of Shandong Province (Grant No.ZR2021ME096)the Youth Innovation Team Project of Shandong Provincial Education Department (Grant No.2019KJJ012)。
文摘Pb(Mg_(1/3)Nb_(2/3))O_(3)–PbTiO_(3)(PMN-PT)piezoelectric ceramics have excellent piezoelectric properties and are used in a wide range of applications.Adjusting the solid solution ratios of PMN/PT and different concentrations of elemental doping are the main methods to modulate their piezoelectric coefficients.The combination of these controllable conditions leads to an exponential increase of possible compositions in ceramics,which makes it not easy to extend the sample data by additional experimental or theoretical calculations.In this paper,a physics-embedded machine learning method is proposed to overcome the difficulties in obtaining piezoelectric coefficients and Curie temperatures of Sm-doped PMN-PT ceramics with different components.In contrast to all-data-driven model,physics-embedded machine learning is able to learn nonlinear variation rules based on small datasets through potential correlation between ferroelectric properties.Based on the model outputs,the positions of morphotropic phase boundary(MPB)with different Sm doping amounts are explored.We also find the components with the best piezoelectric property and comprehensive performance.Moreover,we set up a database according to the obtained results,through which we can quickly find the optimal components of Sm-doped PMN-PT ceramics according to our specific needs.
文摘多发性骨髓瘤(multiple myeloma,MM)为血液系统发病率位居第二位的常见恶性肿瘤,其主要特征之一是基因的异质性。长链非编码RNA(long non-coding RNA,lncRNA)的数目异常与MM的恶性度存在密切关系。伴随新的分子生物学技术的进步,如原位荧光杂交(fluorescence in situ hybridization,FISH)、高通量测序(high-throughput sequencing)、基因芯片(gene microarray)和定量聚合酶链反应(quantitative real time polymerase chain reaction,qRT-PCR)对MM的细胞遗传学异常的研究有了较大拓展。本文针对11种新发现的lncRNA来阐释MM的不同机制。lncRNA有望成为诊治MM的潜在靶点。
文摘目的:分析来那度胺、硼替佐米及地塞米松(lenalidomide,bortezomib and dexamethasone,RVD)方案治疗新诊断多发性骨髓瘤(newly diagnosed multiple myeloma,NDMM)患者的疗效和安全性.方法:回顾性分析2015年1月至2019年5月首都医科大学附属北京朝阳医院收治的48例NDMM患者,统计其临床特征及治疗疗效.结果:48例患者的中位年龄为59(34~79)岁,Durie-Salmon分期Ⅲ期患者44例;ISS分期Ⅱ期患者15例,Ⅲ期患者19例,12例伴浆细胞瘤,细胞遗传学高危患者占32.5%.全部患者接受RVD方案化疗,中位4(1~9)个周期,总有效率97.9%,完全缓解(complete response,CR)率为35.4%,4个周期较2个周期化疗后非常好的部分缓解(very good partial response,VGPR)以上疗效提高为(84.6% vs. 64.1%);平均采集CD34+细胞数4.2(±2.6)×106/kg;诱导治疗后下一代流式微小残留病变(minimal residual disease,MRD)阴性率为20.6%,其中2例移植前MRD阳性者在移植后MRD转阴.治疗过程中2例发生3~4级血液学毒性,未发生3级以上非血液学不良事件.结论:采用RVD方案治疗NDMM患者4个疗程,缓解率高,不良反应可耐受,且不影响干细胞采集.RVD诱导联合自体造血干细胞移植可进一步提高MRD阴性率.
